Factors Predicting Outcome in Stroke Patients Treated With 0.6 mg/kg Alteplase: Evidence From the Japan Alteplase Clinical Trial (J-ACT)
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Clinical Neurology,Rehabilitation,Surgery
Reference20 articles.
1. Japan Alteplase Clinical Trial (J-ACT) Group. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT);Yamaguchi;Stroke,2006
2. Tissue plasminogen activator for acute ischemic stroke;National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group;N Engl J Med,1995
3. Generalized efficacy of t-PA for acute stroke: Subgroup analysis of the NINDS t-PA Stroke Trial;NINDS t-PA Stroke Study Group;Stroke,1997
4. Recanalization after thrombolysis in stroke patients: Predictors and prognostic implications;Zangerle;Neurology,2007
5. CLOTBUST Investigators. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator;Molina;Stroke,2004
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk factors of hemorrhagic transformation in acute ischaemic stroke: A systematic review and meta-analysis;Frontiers in Neurology;2023-02-20
2. Benefit of Intravenous Alteplase before Thrombectomy Depends on ASPECTS;Annals of Neurology;2022-07-15
3. The Impact of Loading Dose on Outcome in Stroke Patients Receiving Low-Dose Tissue Plasminogen Activator Thrombolytic Therapy;Drug Design, Development and Therapy;2020-01
The Impact of Loading Dose on Outcome in Stroke Patients Receiving Low-Dose Tissue Plasminogen Activator Thrombolytic Therapy
4. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator;Journal of the Neurological Sciences;2014-10
5. Early Neurologic Improvement Based on the National Institutes of Health Stroke Scale Score Predicts Favorable Outcome within 30 Minutes after Undergoing Intravenous Recombinant Tissue Plasminogen Activator Therapy;Journal of Stroke and Cerebrovascular Diseases;2014-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3